Industry Sponsorship and Financial Conflict of Interest in the Reporting of Clinical Trials in Psychiatry

2007 ◽  
Vol 2007 ◽  
pp. 113
Author(s):  
R.J. Frances
2005 ◽  
Vol 162 (10) ◽  
pp. 1957-1960 ◽  
Author(s):  
Roy H. Perlis ◽  
Clifford S. Perlis ◽  
Yelena Wu ◽  
Cindy Hwang ◽  
Megan Joseph ◽  
...  

2001 ◽  
Vol 27 (2-3) ◽  
pp. 149-162 ◽  
Author(s):  
Jerome P. Kassirer

Financial conflict of interest has become one of the most contentious issues in medicine today. Several decades ago studies disclosed that physicians who had investments in medical facilities were referring patients for more tests and procedures than physicians who had no such investments. More recently, physicians who forego expensive tests and treatments for patients have been accused of skimping on care for personal financial gain. Physicians who emphatically tout certain treatments have been criticized for possessing hidden financial ties to the manufacturer of the products. Some physicians engaged in clinical trials have been suspected of enrolling patients who do not strictly conform to the research protocols so that they can collect fees from contract research organizations. And in the aftermath of deaths and complications in gene therapy experiments, some scientists and their institutions have been criticized for possessing a financial stake in companies that are involved in the studies.


2019 ◽  
Vol 34 (3) ◽  
pp. 429-434 ◽  
Author(s):  
Deepa V. Cherla ◽  
Cristina P. Viso ◽  
Julie L. Holihan ◽  
Karla Bernardi ◽  
Maya L. Moses ◽  
...  

2010 ◽  
Vol 40 (2) ◽  
pp. 172-182 ◽  
Author(s):  
D. N. Lathyris ◽  
N. A. Patsopoulos ◽  
G. Salanti ◽  
J. P. A. Ioannidis

2019 ◽  
Vol 46 (4) ◽  
pp. 510-519 ◽  
Author(s):  
Mateus Bertolini Fernandes dos Santos ◽  
Bernardo Antônio Agostini ◽  
Rafael Ratto Moraes ◽  
Falk Schwendicke ◽  
Rafael Sarkis‐Onofre

Sign in / Sign up

Export Citation Format

Share Document